ARCHIVES

NCCN and Pfizer Issue RFP In Renal Cell Carcinoma Or Hematologic Malignancies

This article is from The Cancer Letter archive.

Vol. 39 No. 40 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Drug Discovery Group Announcement Issued

January 7, 1983

DCPC Advisors Approve Five New RFA concepts, Set Aside $33.6 Million

June 4, 1993

High-Dose Vitamin D With Docetaxel In Testing For Advanced Prostate Cancer

September 27, 2002

DCCR Gets Go Ahead For New Community Clinical Oncology Program, $600,000 – $1 Million a Year

May 12, 1978

NCI RFP Available.

February 11, 2000

NCI Study Fails To Support Finding Of Excess Cancer In Utah Nuclear Fallout Areas

January 23, 1987